CRMD
CorMedix Inc.Company Information
- Company Name
- CorMedix Inc.
- CIK
- CIK0001410098
- Category
- Non-accelerated filer
- Ticker: Exchange
- CRMD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CRMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-10-23
- Last sale
- 2026-01-21
- Shares purchased (TTM)
- 25,000
- Shares sold (TTM)
- 388,121
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 43,113,754
- Shares outstanding
- 78,444,000
- Ownership
- 54.96%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 3.56%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 257 | 178 | 145 | 48 | 159 | 66 | 41 | 35 | 29 | 35 | 44 | 53 | ||||||
| Short Term Investments | 0 | 0 | 4 | 7 | 31 | 11 | 11 | 11 | 17 | 23 | 32 | 33 | ||||||
| Restricted Cash Current | - | - | 0 | - | - | - | 0 | - | - | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 161 | 155 | 171 | 159 | 43 | 55 | 52 | 17 | 0 | - | - | - | ||||||
| Inventory Net | 39 | 31 | 30 | 29 | 10 | 7 | 8 | 7 | 4 | 2 | 2 | - | ||||||
| Prepaid Expense Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 24 | 19 | 18 | 16 | 5 | 5 | 4 | 3 | 3 | 2 | 1 | 1 | ||||||
| Assets Current | 481 | 383 | 367 | 260 | 248 | 145 | 115 | 73 | 53 | 63 | 79 | 89 | ||||||
| Property Plant And Equipment Net | 8 | 6 | 6 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Assets | - | - | - | - | 1 | 1 | - | - | - | - | - | - | ||||||
| Other Long Term Investments | 27 | 24 | 24 | 23 | - | - | 0 | - | - | - | - | - | ||||||
| Goodwill | 30 | 30 | 30 | 18 | - | - | - | - | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 358 | 369 | 379 | 390 | 2 | 2 | 2 | 2 | - | - | - | - | ||||||
| Restricted Cash Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | 0 | 3 | 16 | 53 | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | - | - | 3 | 3 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Right Of Use Asset | - | - | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Assets | 904 | 816 | 826 | 751 | 253 | 150 | 119 | 78 | 58 | 68 | 82 | 91 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 10 | 13 | 8 | 20 | 6 | 2 | 2 | 1 | 3 | 3 | 4 | 2 | ||||||
| Accrued Liabilities Current | 173 | 113 | 162 | 109 | 26 | 32 | 32 | 17 | 8 | 7 | 7 | 5 | ||||||
| Operating Lease Liability Current | - | - | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Current | - | - | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 187 | 129 | 174 | 134 | 32 | 34 | 34 | 18 | 11 | 10 | 11 | 8 | ||||||
| Deferred Tax Liabilities Other | 145 | 145 | 145 | 145 | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | - | - | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Finance Lease Liability Noncurrent | - | - | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 2 | 3 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 443 | 379 | 421 | 377 | 32 | 35 | 34 | 19 | 12 | 10 | 12 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 573 | 575 | 582 | 565 | 520 | 434 | 424 | 412 | 396 | 394 | 392 | 390 | ||||||
| Retained Earnings Accumulated Deficit | -112 | -138 | -177 | -191 | -299 | -319 | -340 | -353 | -350 | -336 | -322 | -307 | ||||||
| Stockholders Equity | 461 | 437 | 405 | 374 | 221 | 115 | 85 | 59 | 46 | 58 | 70 | 83 | ||||||
| Liabilities And Stockholders Equity | 904 | 816 | 826 | 751 | 253 | 150 | 119 | 78 | 58 | 68 | 82 | 91 | ||||||
| Restricted Cash | - | - | - | 1 | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | 160 | ||||||
| Common Stock Shares Issued | 78 | 78 | 79 | 78 | 75 | 68 | 64 | 58 | 55 | 55 | 55 | 55 | ||||||
| Shares Outstanding | 78 | 78 | 79 | 78 | 75 | 68 | 64 | 58 | 55 | 55 | 55 | 55 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCorMedix Inc. (CRMD) — SEC Financial Statements & Analysis
CorMedix Inc. (CRMD) is a pharmaceutical preparations company, incorporated in DE. CorMedix Inc. trades on Nasdaq as: CRMD. CorMedix Inc. (CRMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, CorMedix Inc. carries a market cap of $615.79M, a P/E ratio of 3.29x, a P/B ratio of 1.34x, a P/S ratio of 1.33x, an enterprise value of $358.11M, and an EV/EBITDA multiple of 1.50x. On profitability, it posts a gross margin of 82.78%, an operating margin of 46.95%, a net margin of 40.49%, a Return on Equity (ROE) of 54.93%, a Return on Assets (ROA) of 32.36%, and a Return on Invested Capital (ROIC) of 157.25%. Per share, it reports EPS of $2.39, diluted EPS of $2.02, free cash flow per share of $3.19, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 280.50% year-over-year, net income growth of 265.86% year-over-year, and EPS growth of 216.81% year-over-year. On the balance sheet, it maintains a current ratio of 2.56x, a quick ratio of 2.23x, working capital of $293.16M, a debt-to-equity ratio of 0.96x, a debt ratio of 0.49, an interest coverage ratio of 78.49x, free cash flow of $250.42M (TTM), and net debt of $-257.68M. Figures sourced from SEC EDGAR.
- Market Cap
- $615.79M
- P/E TTM
- 3.29x
- EPS TTM
- $2.39
- P/B TTM
- 1.34x
- ROE TTM
- 54.93%
- ROA TTM
- 32.36%
- Debt To Equity
- 0.96x
- Free Cash Flow TTM
- $250.42M
- Net Revenue TTM Growth 1Y
- 280.50%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CorMedix Inc. in?
CorMedix Inc. (CRMD) operates in the Pharmaceutical Preparations industry.
What exchange does CRMD trade on?
CorMedix Inc. (CRMD) trades on the Nasdaq.
Where is CorMedix Inc. incorporated?
CorMedix Inc. is incorporated in DE.
When was CorMedix Inc. (CRMD)'s most recent SEC filing?
CorMedix Inc. (CRMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is CRMD's market cap?
CorMedix Inc. (CRMD) has a market capitalization of $615.79M as of 2026-06-30.
What is CRMD's P/E ratio?
CorMedix Inc. (CRMD)'s trailing twelve month P/E ratio is 3.29x as of 2026-06-30.
What is CRMD's EPS (earnings per share)?
CorMedix Inc. (CRMD)'s trailing twelve month EPS is $2.39 as of 2026-06-30.
What is CRMD's ROE (return on equity)?
CorMedix Inc. (CRMD)'s trailing twelve month Return on Equity (ROE) is 54.93% as of 2026-06-30.
What is CRMD's ROA (return on assets)?
CorMedix Inc. (CRMD)'s trailing twelve month Return on Assets (ROA) is 32.36% as of 2026-06-30.
What is CRMD's ROIC (return on invested capital)?
CorMedix Inc. (CRMD)'s trailing twelve month Return on Invested Capital (ROIC) is 157.25% as of 2026-06-30.
What is CRMD's EV/EBITDA?
CorMedix Inc. (CRMD)'s trailing twelve month EV/EBITDA is 1.50x as of 2026-06-30.